[New patients with end-stage renal disease on chronic dialysis].
The aim of this study was to analyse outcome of new ESRD patients on haemodialysis. We analysed nember, demographic data, renal disease and mortality of new ESRD patients on haemodialysis (HD) in 16-months period. We dialysed for the first time 74 patents with ESRD, 37 female (50%) and 37 male, average age 55.55 +/- 13.57 yrs. There were 3 patients younger than 30 yrs, 51 between 31-65 and 20 were older than 65 yrs. 29.73% of these patients were from Tuzla. Distribution of patients according to primary renal disease was: glomerulonephritis 20.77%, pyelonephrtis 14.86%, diabetes mellitus 13.86%, 29.74% others and 20.77% unknown. 11 patents (14.86%) were on HD less than 10 days, 11 patents (14.86%) were on HD less than 3 months, 35 patients (47.30%) were on HD less than 12 months, and 17 patients (22.98%) were on HD more than 12 months. 46 patients (62.16%) are still on HD, 18 (24.32%) died, 3 (4.05%) temporary stopped with HD treatments, 3 transplanted, for 3 there are no data, and 1 patient (1.35%) transferred in other center. Causes of death were as follows: unknown in 5 (27.78%), gynaecology carcinoma in 3 (16.67%), sepsis in 3 (16.67%), cardiovascular disease in (11.11%), cerebrovascular accident in 2 (11.11%), and others in 3 (4.05%) patients. In the group of died patients were 13 women (72.22%) and 5 men, average age 56.94? 13.09 yrs (28-61). Leading primary renal diseases was glomerulonephitis, pyelonephritis and diabetes. Significant percent of new ESRD patients on HD die very early, and 77% of the patients live on HD less tan 12 months.